ReviewFrontiers in molecular biosciences2022

Shared pathobiology identifies AMPK as a therapeutic target for obesity and autosomal dominant polycystic kidney disease.

Ioan-Andrei Iliuta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.